Risk of residual cancer after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumour and international germ cell cancer cooperative group intermediate/poor prognosis: a multi-institutional retrospective cohort study

HIGHLIGHTS

• who: Luca Antonelli from the Department of Urology, Luzerner Kantonsspital, University of Lucerne, Switzerland have published the paper: Risk of residual cancer after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumour and International Germ Cell Cancer Cooperative Group intermediate/poor prognosis: A multi-institutional retrospective cohort study, in the Journal: (JOURNAL)
• what: The aim of this study is to provide additional data regarding the proportion of residual cancer in the retroperitoneum at the time of pcRPLND and the risk of L Antonelli et_al / European Journal of Cancer 182 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.